On May 1, 2023 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS) reported its first quarter 2023 financial results will be released after market close on Monday, May 8, 2023 (Press release, Coherus Biosciences, MAY 1, 2023, View Source/news-releases/news-release-details/coherus-biosciences-report-first-quarter-2023-financial-results" target="_blank" title="View Source/news-releases/news-release-details/coherus-biosciences-report-first-quarter-2023-financial-results" rel="nofollow">View Source [SID1234630764]). Starting at 5:00 pm ET on May 8, 2023, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A replay of the webcast will be available on View Source following the conclusion of the live conference call.
Conference Call Information
When: Monday, May 8th, 2023, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI12e6d284dae8440e91891f2cef4f2097
Webcast: View Source
The press release with the first quarter financial results and related materials will be available at View Source prior to the start of the conference call.
A live and archived webcast will be available on the "Investors" section of the Coherus website at View Source.
Please dial-in 15 minutes early to ensure a timely connection to the call.